Search
Search Results
##search.searchResults.foundPlural##
-
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1362PDF: 528HTML: 197 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
996PDF: 988Suppl. Files: 636HTML: 127 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3771PDF: 1483HTML: 485Figures . Eliassian: 222 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4042PDF: 1151HTML: 1935Fig.1: 219Fig. 2: 111Table 1: 201Table2: 219Table 3: 199 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2218PDF: 964HTML: 1897 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2307PDF: 954HTML: 11129 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1463PDF: 762Suppl. Files: 323Html: 136 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1037PDF: 926Suppl. Files: 594HTML: 83 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2875PDF: 1099HTML: 3029 -
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis
205PDF: 214HTML: 13 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2491PDF: 922HTML: 530 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1768PDF: 1073HTML: 249 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2066PDF: 1046HTML: 15650COVER LETTER: 190 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2579PDF: 862HTML: 17469Fig1 Caligaris: 172Fig.2 Caliga: 203 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2030PDF: 823HTML: 213 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1223PDF: 591HTML: 2860ATRA induced Reactive Hemophagocytosis: A Case Report: 197 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
876PDF: 685HTML: 320 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3316PDF: 1237HTML: 2199 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2544PDF: 870HTML: 2122 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2133PDF: 1275Html: 283 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3219PDF: 1431HTML: 5845Fig1-Ag-Pil: 226Ag-Pil Fig.2: 227 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3742PDF: 1562HTML: 8032Randi Fig: 181 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1390PDF: 819HTML: 3123 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3554PDF: 1067HTML: 874 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1588PDF: 976HTML: 189 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1239PDF: 648HTML: 7727 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1300PDF: 564Suppl. Files: 346HTML: 144 -
Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States Worldwide distribution of PK deficiency:
1054PDF: 263HTML: 151 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3246PDF: 1612HTML: 429 -
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
1928PDF: 1099HTML: 1892Lung computed tomography CT scan image: 201 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1823PDF: 798HTML: 3600 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2280PDF: 1821HTML: 144







